Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.35EBIT per Share
VS
Market
Sector
Industry
History
$ 1.82Close
$ 1.53 - $ 2.27 52-Week Range
Ticker Information
Ticker
APUSCompany Name
APIMEDS PHARMACEUTICALS US INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEMKTAPIMEDS PHARMACEUTICALS US INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APUS - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -3.58M | $ -0.35 | 1 | 10.37M |
| 3/31/2025 | $ 0 | $ 0 | 1 | 7.9M |
| 12/31/2024 | $ -1.27M | $ -0.16 | 1 | 7.9M |
| 9/30/2024 | $ 0 | $ 0 | 1 | 7.9M |
| 6/30/2024 | $ 0 | $ 0 | 1 | 7.9M |
| 12/31/2023 | $ -739.63K | $ -0.16 | 1 | 4.6M |
Key Performance Insights, Last 5 Years
- APIMEDS PHARMACEUTICALS US INC's latest trailing twelve months (TTM) EBITPS stands at $ -0.16.
- Over the past 5 years, APIMEDS PHARMACEUTICALS US INC's average EBITPS has been $ -0.22.
- The median EBITPS for APIMEDS PHARMACEUTICALS US INC during this period was $ -0.16
- APIMEDS PHARMACEUTICALS US INC reached its highest EBITPS over the past 5 years at $ -0.16.
- The lowest EBITPS recorded by APIMEDS PHARMACEUTICALS US INC in the same timeframe $ -0.35
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for APIMEDS PHARMACEUTICALS US INC is calculated as follows: EBIT [ $ -739.63K ] / (Shares WA [ 4.6M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -0.16 ] APUS - EBIT per Share, Last 5 years
$ -0.35
Minimum
Jun 30, 2025
$ -0.16
Maximum
Dec 31, 2023
$ -0.22
Average
$ -0.16
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.39 |
| std | $ 3.42 |